US2017115314A1PendingUtilityA1
Mass spectrometric determination of cookson-derivatized, non-metabolized vitamin d
Assignee: QUEST DIAGNOSTICS INVEST INCPriority: Dec 11, 2009Filed: Jun 27, 2016Published: Apr 27, 2017
Est. expiryDec 11, 2029(~3.4 yrs left)· nominal 20-yr term from priority
G01N 30/88G01N 30/72H01J 49/004G01N 2030/009G01N 33/82G01N 2030/8813G01N 2030/027H01J 49/145G01N 30/7233
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the detection of vitamin D. In a particular aspect, the invention relates to methods for detecting derivatized vitamin D by mass spectrometry.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A method for determining the amount of non-metabolized vitamin D in a sample by tandem mass spectrometry, the method comprising the steps of:
(i) purifying the sample by liquid-liquid extraction; (ii) subjecting the sample to turbulent flow liquid chromatography (TFLC); (iii) subjecting Cookson-type-derivatized non-metabolized vitamin D from the sample to an ionization source to generate one or more precursor ions detectable by mass spectrometry; (iv) fragmenting at least one of said precursor ions to generate one or more fragment ions detectable by mass spectrometry; (v) determining the amount of one or more precursor and fragment ions by mass spectrometry; and (vi) relating the amount of ions determined in step (iii) to the amount of a non-metabolized vitamin D in the sample.
2 . The method of claim 1 , wherein the Cookson-type-derivatized non-metabolized vitamin D is subjected to an extraction column and an analytical column.
3 . The method of claim 2 , wherein the extraction column is a solid-phase extraction (SPE) column.
4 . The method of claim 2 , wherein the analytical column is a high performance liquid chromatography (HPLC) column.
5 . The method of claim 2 , wherein the extraction and analytical columns and the ionization source of step (i) are connected in an on-line fashion.
6 . The method of claim 1 , wherein said ionization source is an atmospheric pressure chemical ionization (APCI) source.
7 . The method of claim 1 , wherein the Cookson-type derivatizing reagent is selected from the group consisting of 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD), 4-methyl-1,2,4-triazoline-3,5-dione (MTAD), 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl]-1,2,4-triazoline-3,5-dione (DMEQTAD), 4-(4-nitrophenyl)-1,2,4-triazoline-3,5-dione (NPTAD), and 4-ferrocenylmethyl-1,2,4-triazoline-3,5-dione (FMTAD), and isotopically labeled variants thereof.
8 . The method of claim 1 , wherein the Cookson-type derivatizing reagent is 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) or an isotopically labeled variant thereof.
9 . The method of claim 1 , wherein said vitamin D comprises one or more of vitamin D 2 and vitamin D 3 .
10 . The method of claim 9 , wherein the Cookson-type derivatizing reagent is 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD); and said one or more precursor ions comprise one or more ions selected from the group consisting of ions with a mass/charge ratio (m/z) of 572.4±0.5 and 560.4±0.5.
11 . The method of claim 9 , wherein the Cookson-type derivatizing reagent is 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD); and said one or more fragment ions comprise an ion with a mass/charge ratio (m/z) of 298.1±0.5.
12 . The method of claim 1 , wherein two or more non-metabolized vitamin D derivatives are ionized simultaneously.
13 . The method of claim 1 , wherein said sample comprises plasma or serum.
14 . A method for determining the amount of non-metabolized vitamin D in a sample by tandem mass spectrometry, the method comprising the steps of:
(i) purifying the sample by liquid-liquid extraction; (ii) subjecting the sample to turbulent flow liquid chromatography (TFLC); (iii) subjecting Cookson-type-derivatized non-metabolized vitamin D from the sample to an ionization source to generate one or more precursor ions detectable by mass spectrometry; (iv) fragmenting at least one of said precursor ions to generate one or more fragment ions detectable by mass spectrometry, wherein said one or more fragment ions comprise an ion with a mass/charge ratio (m/z) of 298.1±0.5; (v) determining the amount of one or more precursor and fragment ions by mass spectrometry; and (vi) relating the amount of ions determined in step (iii) to the amount of a non-metabolized vitamin D in the sample.
15 . The method of claim 14 , wherein the Cookson-type-derivatized non-metabolized vitamin D is subjected to an extraction column and an analytical column.
16 . The method of claim 15 , wherein the extraction column is a solid-phase extraction (SPE) column.
17 . The method of claim 15 , wherein the analytical column is a high performance liquid chromatography (HPLC) column.
18 . The method of claim 15 , wherein the extraction and analytical columns and the ionization source of step (i) are connected in an on-line fashion.
19 . The method of claim 14 , wherein said ionization source is an atmospheric pressure chemical ionization (APCI) source.
20 . The method of claim 14 , wherein the Cookson-type derivatizing reagent is selected from the group consisting of 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD), 4-methyl-1,2,4-triazoline-3,5-dione (MTAD), 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl]-1,2,4-triazoline-3,5-dione (DMEQTAD), 4-(4-nitrophenyl)-1,2,4-triazoline-3,5-dione (NPTAD), and 4-ferrocenylmethyl-1,2,4-triazoline-3,5-dione (FMTAD), and isotopically labeled variants thereof.Join the waitlist — get patent alerts
Track US2017115314A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.